Drug Discovery
Kyrgyzstan, Ukraine, and Uzbekistan Revise TB Guidelines for Three-Drug Regimen
Kyrgyzstan, Ukraine, and Uzbekistan — participants in the LIFT-TB project — have updated their National Tuberculosis (TB) Clinic...
September 19, 2023 | News
Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug
Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...
September 18, 2023 | News
Exelixis and Insilico Medicine Ink Global License Deal for ISM3091, a Leading USP1 Inhibitor
— ISM3091 is a highly selective, orally bioavailable small molecule inhibitor of USP1 identified through Insilico Medicine's artificial int...
September 14, 2023 | News
Metabolon Debuts Stress Discovery Panel for Biomarker Detection
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, diagnostic, therapeutic development, and preci...
September 13, 2023 | News
Waters Introduces Simplified Solutions for Biologic Drug Analysis
Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and...
September 13, 2023 | News
Singapore's Biosyngen Gets FDA Nod for BRL03 Trials in Advanced Solid Tumors
Notably, BRL03 is also the first TCR-T product developed by Biosyngen to enter clinical trials. This significant achievement is attributed to the...
September 12, 2023 | News
Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment
The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...
September 07, 2023 | News
ACM Biolabs Reports Positive Phase I Results for SARS-CoV-2 Booster Vaccine ACM-001
Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-...
September 06, 2023 | News
"Innovation Down Under: Exploring the Australian BioPharma Industry"
Introduction Nestled on the vast, sunburned continent known for its stunning landscapes and unique wildlife, the Australian BioPharma industry has...
September 05, 2023 | Analysis
ABM Therapeutics Initiates Phase I Study of ABM-1310 in BRAF V600 Brain Tumors
ABM-1310, the company's proprietary clinical candidate developed as a next-generation BRAF inhibitor and demonstrated superior properties in pre-clinical a...
September 04, 2023 | News
South Korea's Genexine's Long-Acting Growth Hormone Meets Phase 3 Endpoint
Phase 3 clinical trial in China meets primary endpoint On track to file BLA in China in 2024 The study being conducted by Genexine’s partner in...
August 31, 2023 | News
Menarini's ELZONRIS® (Tagraxofusp) Receives Orphan Drug Designation for BPDCN by Japanese Ministry of Health
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-own...
August 31, 2023 | Regulatory
Epigenic Therapeutics Raises $32M for Breakthrough Epigenome Medicine Development
This round of financing will support the preclinical development and early clinical validation of two leading programs, discovery of future pipelines, expa...
August 30, 2023 | News
BOC Sciences Introduces a Novel XDC Bioconjugation Platform to Advance Biomedical Research
The newly developed XDC bioconjugation platform offered by BOC Sciences introduces a range of advanced technologies and optimized protocols, revolutionizin...
August 25, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
